Cytokine and chemokine responses to injury and treatment in a nonhuman primate model of hypoxic-ischemic encephalopathy treated with hypothermia and erythropoietin

• Published in: Journal of cerebral blood flow and metabolism Vol. 41; no. 8; pp. 2054 - 2066
• Main Authors: Wood, Thomas R, Vu, Phuong T, Comstock, Bryan A, Law, Janessa B, Mayock, Dennis E, Heagerty, Patrick J, Burbacher, Thomas, Bammler, Theo K, Juul, Sandra E
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.08.2021
• Subjects: Animals; Animals, Newborn; Area Under Curve; Biomarkers - blood; Chemokines - blood; Cytokines - blood; Disease Models, Animal; Erythropoietin - therapeutic use; Female; Hypothermia, Induced; Hypoxia-Ischemia, Brain - drug therapy; Hypoxia-Ischemia, Brain - mortality; Hypoxia-Ischemia, Brain - pathology; Hypoxia-Ischemia, Brain - therapy; Intercellular Signaling Peptides and Proteins - blood; Macaca nemestrina; Monocyte Chemoattractant Proteins - blood; Original; Pregnancy; ROC Curve; Severity of Illness Index; neonatal; Asphyxia; hypothermia; hypoxic-ischemic encephalopathy; erythropoietin
• ISSN: 0271-678X; 1559-7016
• DOI: 10.1177/0271678X21991439

Predicting long-term outcome in infants with hypoxic-ischemic encephalopathy (HIE) remains an ongoing clinical challenge. We investigated plasma biomarkers and their association with 6-month outcomes in a nonhuman primate model of HIE with or without therapeutic hypothermia (TH) and erythropoietin (Epo). Twenty-nine Macaca nemestrina were randomized to control cesarean section (n = 7) or 20 min of umbilical cord occlusion (UCO, n = 22) with either no treatment (n = 11) or TH/Epo (n = 11). Initial injury severity was scored using 30-min arterial pH, base deficit, and 10-min Apgar score. Twenty-four plasma cytokines, chemokines, and growth factors were measured 3, 6, 24, 72, and 96 h after UCO. Interleukin 17 (IL-17) and macrophage-derived chemokine (MDC) differentiated the normal/mild from moderate/severe injury groups. Treatment with TH/Epo was associated with increased monocyte chemotactic protein-4 (MCP-4) at 3 h–6h, and significantly lower MCP-4 and MDC at 24 h–72h, respectively. IL-12p40 was lower at 24 h–72h in animals with death/cerebral palsy (CP) compared to survivors without CP. Baseline injury severity was the single best predictor of death/CP, and predictions did not improve with the addition of biomarker data. Circulating chemokines associated with the peripheral monocyte cell lineage are associated with severity of injury and response to therapy, but do not improve ability to predict outcomes.